|
| [4] | V. Baier, O. Clayton, R. Nudischer, H. Cordes, A. R. P. Schneider, C. W. J. Thiel, T. Wittenberger, W. Moritz, L. M. Blank, U. P. Neumann, C. Trautwein, J. Kelm, Y. Schrooders, F. Caiment, H. Gmuender, A. Roth, J. V. Castell, J. Kleinjans, L. O. Küpfer,
"A Model-Based Workflow to Benchmark the Clinical Cholestasis Risk of Drugs", Clinical pharmacology & therapeutics, vol. 110, no. 5, 2021, pp. 1293–1301.
|
|
| [3] | A. Afrizal, S. A. V. Jennings, T. C. A. Hitch, T. Riedel, M. Basic, A. Panyot, N. Treichel, F. T. Hager, E. O. Wong, B. Wolter, A. Viehof, A. von Strempel, C. Eberl, E. M. Buhl, B. Abt, A. Bleich, R. H. Tolba, L. M. Blank, W. W. Navarre, F. Kießling, H. Horz, N. Torow, V. Cerovic, B. Stecher, T. Strowig, J. Overmann, T. Clavel,
"Enhanced cultured diversity of the mouse gut microbiota enables custom-made synthetic communities", Cell host and microbe, vol. 30, no. 11, 2022, pp. 1630–1645.e25.
|
| [2] | A. R. P. Schneider, C. V. Schneider, K. M. Schneider, V. Baier, S. Schaper, C. Diedrich, K. Coboeken, H. Mayer, W. Gu, J. Trebicka, L. M. Blank, R. Burghaus, J. Lippert, D. J. Rader, C. A. Thaiss, J. Schlender, C. Trautwein, L. Küpfer,
"Early prediction of decompensation (EPOD) score: Non-invasive determination of cirrhosis decompensation risk", Liver international, vol. 42, no. 3, 2022, pp. 640–650.
|
|
| [1] | J. Soppert, E. F. Brandt, N. M. Heussen, E. Barzakova, L. M. Blank, L. Küpfer, M. W. Hornef, J. Trebicka, J. Jankowski, M. Berres, H. Noels,
"Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease: a systematic review and meta-analysis", Clinical Gastroenterology and Hepatology, vol. 21, no. 11, 2023, pp. 2746–2758.
|